这个世界需要英雄

$Shuttle Pharmaceuticals(SHPH.US) shot up +40% directly, but after scouring all the news, there's only an insider Form 4 that doesn't specify the direction of the transaction, plus that previous merger with United Dogecoin and the plan to get into Dogecoin and Litecoin mining rigs—a biotech shell being forcibly turned into a crypto mining story 😵‍💫

This kind of small-cap stock surged from over two dollars to five dollars and then crashed back to four dollars, wildly fluctuating. It's purely driven by themes and sentiment, with no news and no performance. Chasing this is like licking blood off a knife's edge. If you don't have a position, you really shouldn't join the hype.

$Almonty Industries(ALM.US) and $US Antimony(UAMY.US) both fell 7 to 10 points. Strategic minor metals like tungsten and antimony were all sold off today. They had a run-up earlier based on supply chain security and defense demand, and the pullback is just as fierce. High-beta minor metal mines are the first to get hit when the market turns risk-off. 😔

$Forte Biosciences(FBRX.US) rose +19.7%. FB102 achieved its key objective in vitiligo research, with data also showing durable improvement. The clinical data is solid, and the market cap has more than quintupled in a year, now around $900M.

For a Biotech after data is delivered, the next step is to wait for data from the next indication to take over, or to take profits first? Behind FB102 are a string of indications like celiac disease, alopecia areata, and type 1 diabetes. Each one is an option, but each one also requires burning cash.

I guess the market will first digest this rally in the short term—the data release day is often the peak of sentiment for that phase.

$Julong(JLHL.US) surged over 300% in a single day, with trading volume spiking to more than two hundred times its usual level. Scouring all the news reveals no decent catalyst; it's purely a case of a low float being ignited by capital. $Republic Power(RPGL.US) rose over 30%, at least there's a reason—it resolved its Nasdaq listing compliance issues.

With this kind of pulse-like surge, are there really that many buyers who can withstand the next day? Those without positions shouldn't try to catch a falling knife. Those with positions should set their stop-losses firmly first. The pullback on these kinds of stocks is often faster than the rise.

Industrial metals showed a quite divergent performance today: $Albemarle(ALB.US) fell over three percentage points, $US Antimony(UAMY.US) dropped even more sharply, over six percentage points, while $CHINAHONGQIAO(01378.HK) barely moved. Lithium prices are still bottoming out, putting pressure on $Albemarle(ALB.US), which follows lithium. Antimony, a minor metal, has a thin market, so volatility is high with any slight disturbance. $CHINAHONGQIAO(01378.HK) mainly produces electrolytic aluminum and also copper. Aluminum prices have been relatively stable recently, helping it to hold up. Even though they are all non-ferrous metals, the drivers behind lithium and antimony falling while aluminum stabilizes are completely on different price levels.

$LINGYI ITECH(01688.HK) fell 12%, $ZHIDA TECH(02650.HK) fell 12%, and $LIULIUMEI(06658.HK) fell 10%. Three Hong Kong-listed secondary new shares collectively saw double-digit pullbacks on the same day.

$LINGYI ITECH(01688.HK) is in the Apple supply chain/AI hardware direction. It broke its issue price upon listing and hit the daily down limit directly on this day, compounded by the adjustment in the AI hardware sector. $ZHIDA TECH(02650.HK) makes home charging piles, and $LIULIUMEI(06658.HK) makes green plum snacks. Both surged sharply after their initial listings and then gave back their paper profits along with the broader market in this round. Secondary new shares lack institutional holding consolidation, so their decline slope during a theme's ebb is often much steeper than that of seasoned stocks.

$LUNG FUNG GROUP(02290.HK) surged over 14%. The trigger point was the just-announced annual profit increase of +57% year-on-year, coupled with the end of the post-IPO price stabilization period where underwriters no longer support the price. After this suppression was removed, the price made a one-time upward adjustment.$BUSYMING(01768.HK) rose nearly 10% here. The logic is its inclusion in the Stock Connect (for Hong Kong) and Macquarie raising its profit forecast and target price—both events serve to attract incremental capital and institutional attention.

Both are secondary new consumer stocks, relying on solid performance and capital market events, not sentiment-driven pumps. This kind of driver is more solid than pure thematic plays, but secondary new stocks have high volatility, so position sizing must be controlled when chasing.

$Regencell Bioscience(RGC.US) dropped -21% in a single day. The previous short-squeeze style impulse is receding, with profit-taking concentrated for settlement.

It's still shadowed by securities litigation and a DOJ subpoena, and the company itself has no actual revenue to support it, with valuation purely driven by sentiment. For a target like this without a fundamental foundation, the decline is often more decisive than the rise, and any rebound is likely just a one-time correction of oversold sentiment.

$US Antimony(UAMY.US) rose six points, as it began delivering on its $245 million Defense Logistics Agency antimony supply contract—the first shipment of over 80,000 pounds of antimony ingots was sent, with an invoice of $2.6 million issued. Cumulative government orders have now exceeded $57 million, and capacity is still being expanded.

$Energy Fuels(UUUU.US) fell slightly by two points on the uranium side. Uranium prices haven't seen much movement, following the overall weakness in commodities. It's still waiting for its own price and policy catalysts.

$AT & T(T.US) fell by more than five percentage points. Oppenheimer downgraded its rating from Outperform to In-Line, citing that SpaceX's direct-to-cell satellite retail mobile service poses a structural threat to its broadband and mobile user base. The institution also lowered its fiber-to-the-home target from 60 million households to about 50 million households. This is compounded by its recent removal from the Russell Top 50 Index, which triggered passive fund selling, creating a dual pressure scenario.

For high-dividend defensive telecom stocks like this, once the narrative shifts from stable cash flow to being structurally bypassed, the valuation anchor needs to be re-evaluated. Is this round of direct-to-cell satellite threats from SpaceX just another "crying wolf" analyst narrative, or will it truly shake the moat of telecom operators within two to three years?

It looks more like the former being overpriced—the capacity and pricing structure of direct-to-cell satellites cannot replace mainstream broadband in the short term. However, the stock's reaction this time indicates the market has already started pricing this tail risk into the discount rate.

$JIAXIN INTL RES(03858.HK) rose slightly, $TIANQI LITHIUM(09696.HK) gained over two percentage points, and $US Antimony(UAMY.US) dipped marginally. The small-cap lithium and rare earth stocks diverged today — $JIAXIN INTL RES(03858.HK) has lithium projects in Canada; $TIANQI LITHIUM(09696.HK) is an SQM shareholder + mainland lithium mining side; $US Antimony(UAMY.US) is a small-cap antimony miner.

Lithium prices have seen a marginal rebound after bottoming out in June, which is a short-term catalyst for lithium mining stocks. Antimony, as a military metal, faces tight supply-demand in 2026, but $US Antimony(UAMY.US) has too small a market cap and poor liquidity. If choosing one for long-term holding among the three, $TIANQI LITHIUM(09696.HK) has the highest asset quality + lowest valuation.

$FuelCell Energy(FCEL.US) landed a major order: signed a supply agreement with Fit Energy for up to 380MW of data center fuel cells, with the first 30MW batch already receiving an advance payment, and delivery is set to begin within the year.

The catalyst wasn't the quarterly report, but the confirmation of the main theme of AI data center power shortages—multiple analysts raised their target prices that same day.

The stock price jumped over 20%, and low-level holdings from earlier periods began to change hands; looking at the product orders, the 4GW potential pipeline has reopened the imagination for revenue valuation over the next 1-2 years.

$HJ SCIENCE-B(06132.HK) has dropped another -10%. This new biotech stock was halved directly within the first two days of its IPO. The high pricing around the issue price was quickly disproven in the secondary market. Those who got allocated shares in the IPO are now likely deeply trapped, while those watching from the sidelines are torn—with the stock breaking its issue price to this extent, is it an opportunity for a rebound play, or has the digestion of its high valuation only just begun? I lean more towards the latter. During a sentiment downturn, the price correction for biotech IPOs is often continuous; after being halved on the first day, it rarely hits the bottom in one go. It's safer to wait for trading volume to shrink and for shares to change hands more fully before taking another look.

$Pulsenmore(PLSM.US) surged +93% in a single day, catalyzed by being selected by Ouma Health, a leading U.S. maternity and postpartum telemedicine platform, as the home ultrasound entry point, and FDA approval has also been granted. The story itself is true.

The question is, for such a micro-cap medical device stock, can a partnership with one major client support a doubled valuation, or will the sentiment be exhausted in just a few days? The latter is more likely — there's a long gap between a single partnership landing and actual revenue realization. Those without positions shouldn't FOMO buy on this +93% day 🙈

The non-ferrous metals sector is experiencing severe internal divergence. $TIANQI LITHIUM(09696.HK) rose slightly, showing signs of a rebound in the lithium sector. However, $US Antimony(UAMY.US) fell -10%, $Global X Copper Miners(COPX.US) dropped six points, $Alcoa(AA.US) also declined by five or six points, and $CHIFENG GOLD(06693.HK) dipped slightly. They are all bulk metals, so why is lithium rising while copper, aluminum, antimony, and gold are all falling? A strong US dollar and the breakdown in copper prices are the main reasons. Industrial metals are being hit by both weak demand and the strong dollar, while lithium's rise is an oversold rebound after falling for over a year. Their respective cycle positions are different, making it hard to expect them to move in sync in the short term.

The batch of cyclical resources and the automotive supply chain was generally weak today. $GWMOTOR(02333.HK) barely moved, $Albemarle(ALB.US) and $LOPAL TECH(02465.HK) both fell two to three percentage points. Lithium mining and lithium battery materials continued to grind along with the weakness in lithium prices; $Almonty Industries(ALM.US), this tungsten mining stock, also barely moved. The upstream/cyclical chain of vehicles, lithium, and tungsten is basically experiencing a slow decline or sideways movement in an environment where demand data shows no improvement and the US dollar remains strong, lacking independent catalysts. Before lithium prices hit bottom, any rebound in the materials sector will be quite forced. 🫠

$INSILICO(03696.HK) has surged by over a dozen points, and the catalysts are quite clear: ISM8969, an NLRP3 inhibitor discovered by AI, has completed its first human dosing in collaboration with Hengtai Biotech, marking the first true clinical milestone in its AI drug development pipeline. At the same time, it was included in the FTSE Global Index, and passive funds typically front-run before the effective date. One fundamental milestone and one capital flow factor combined, this rally has a solid basis and is not purely speculative.

$COSCO SHIP ENGY(01138.HK) has risen nearly 20%, and $DONGYUE GROUP(00189.HK) has gained nine percentage points. Both are cyclical stocks ignited by price prosperity, but the ignition sources are different.

$COSCO SHIP ENGY(01138.HK) is following the oil shipping supercycle—VLCC freight rates have been running high this year, with geopolitical risk premiums in the Middle East occasionally adding fuel, directly impacting the stock prices of these pure tanker plays through freight rate elasticity. However, there wasn't a new piece of data on soaring freight rates today; it seems more like another round of heating up due to the cycle combined with geopolitical sentiment. The sustainability of this magnitude still depends on whether the subsequent VLCC daily charter rates can hold.

$DONGYUE GROUP(00189.HK) is about refrigerants. The prices of third-generation refrigerants have been rising during the final window of quota tightening, with varieties like R32 hitting decade-highs for the same period. Low inventory during the peak season adds another boost, and expectations of gross margin improvement are being repriced. The commonality between the two is supply constraints coupled with rising prices, with the difference being that freight rates are a daily variable, while refrigerants move on a quarterly scale.

$Gelteq(GELS.US) is up +197% today, with the volume ratio off the charts; $TMD Energy(TMDE.US) rose nearly twenty points, with a volume ratio of 17x; $UTime(WTO.US) dropped -15% in the opposite direction, with a volume ratio of 112x.

All three are ultra-micro-cap stocks with no new news: $Gelteq(GELS.US)'s last substantial announcement was about setting up a center in Guangdong a week ago, $UTime(WTO.US) is experiencing a sell-off after a previous surge, and $TMD Energy(TMDE.US) deals with marine fuel in Malaysia, with a market cap so small that funds can easily manipulate it.

The water level for micro-cap stocks has clearly been rising recently. The ups and downs of these small stocks with no institutional coverage have nothing to do with fundamentals. Touching them is like flipping a coin.

$Uranium Energy(UEC.US) dropped by more than ten points, with a cumulative pullback of over 20% in two days. FQ3 reported a loss of $0.11 per share, missing the market expectation of -$0.03, with the loss magnitude nearly four times the forecast. Free cash flow was -$21 million for the quarter. Uranium prices themselves are fine, with spot prices around $85 basically unchanged. The sector was just dragged down by the broader market; this move is specific to its own fundamentals.

From the peak in early June, the pullback has reached -36%. Sell-offs driven by earnings reports typically require waiting for price and volume to stabilize before considering entry, and there's currently insufficient reason to buy now.

$Jiuzi(JZXN.US) rose by over eight percentage points, with trading volume surging sevenfold—but Bitcoin itself is falling. A company that started as a new energy vehicle dealer, transformed itself into a crypto stock through a treasury plan to "buy 10,000 Bitcoins with $1 billion." The coin falls, the stock rises. What's really being priced here: the coin price or the narrative itself?

It looks more like a narrative play: the float is small, previous rounds of private placements were made using crypto assets as investment, and the correlation between the stock price and the coin price is actually the weakest link. When the coin price truly starts trending down, the premium/discount of such treasury stocks will eventually have to be reconciled.

$Marvell Tech(MRVL.US) Semiconductors rebounded, up 9.6% in a day, and the custom ASIC story continues to unfold—would you bet on custom chips or stick with NVIDIA's GPU?

$Xos(XOS.US) plummeted -29% in a single day. I looked around but couldn't find any substantial announcements or earnings reports. Small-cap stocks like commercial electric trucks inherently have thin liquidity. A 30% intraday swing looks more like a stampede of speculative positions than a fundamental collapse. For this kind of newsless crash, should we treat it as a mispriced opportunity to buy, or as a liquidity trap to avoid? I'd choose to avoid it. A sharp drop in a small-cap stock without any catalyst often has a second wave. It's not too late to wait until it stabilizes and there's volume confirmation.

Volato rose +45%, having just announced a partnership with M2i Global for gold tokenization, riding the hype of both gold and tokenization; Namib Minerals also rose +36%, a small mining company that's actually digging for gold in Zimbabwe.

Both are tied to gold, one relying on concept and the other on production, with a vast difference in their actual 'gold content'. When gold prices are high, these small-cap stocks are particularly susceptible to being ignited by market sentiment. Should they be viewed as flexible tools for gold exposure, or purely as thematic momentum plays? It looks more like the latter—especially for Volato's announcement-driven rally, don't take it seriously before anything concrete materializes.

Amprius +22%, Palladyne AI +17%, Nova Minerals and MagnaChip Semiconductor all rose +14% — four independent stocks showing significant gains together. Amprius is riding on rumors of volume expansion for silicon anode batteries, Nova Minerals is benefiting from expectations of U.S. domestic supply chain policies along with antimony/critical metal ADRs, MagnaChip broke out with a single-day gap in the small-cap semiconductor sector, and Palladyne AI is following the sentiment of the AI robotics sector. All four are small-cap stocks valued between $500 million and $1.5 billion, where a single day's capital push can drive gains of over ten to twenty percent.

The question is: how many trading days can this kind of 'small-cap + theme' surge last? I feel it's probably just a one-day affair — unless Amprius secures real orders or Nova Minerals gets a specific contract from the U.S. Department of Defense, otherwise the capital won't stay.